Feel Free Drink Controversy Explained: Kratom, Lawsuits, and What Users Must Know
A central question remains: how did an addictive, opioid-receptor-binding concoction land on conventional grocery shelves without clinical trial review? The answer lies in the Dietary Supplement Health and Education Act of 1994 (DSHEA). Under this federal statute, the FDA lacks pre-market approval authority over products categorized as dietary supplements. Manufacturers are not mandated to demonstrate safety or efficacy before placing items into interstate commerce; the federal agency can intervene only after clear evidence of widespread public harm emerges.
Kratom occupies a long-standing gray zone in federal law. The Drug Enforcement Administration attempted to classify kratom as a Schedule I controlled substance in 2016, but intense pushback from consumer lobbies and trade advocates stalled the initiative. Consequently, companies operate in an uneven regulatory landscape. While individual states like Alabama, Indiana, and Wisconsin passed statutory bans on kratom, other jurisdictions permit unfettered retail sales to consumers of any age.
Botanic Tonics exploited this fractured framework, keeping the drink accessible to teenagers, athletes, and unwitting professionals. While modern production batches carry fine-print disclaimers cautioning against consuming more than one-half of a bottle per day, critics and health authorities stress that single-serving screw-top bottles naturally encourage immediate, complete consumption.
